Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Modeling Parkinson's disease using induced pluripotent stem cells.

Byers B, Lee HL, Reijo Pera R.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):237-42. doi: 10.1007/s11910-012-0270-y. Review.

2.

Parkinson's disease in a dish - Using stem cells as a molecular tool.

Badger JL, Cordero-Llana O, Hartfield EM, Wade-Martins R.

Neuropharmacology. 2014 Jan;76 Pt A:88-96. doi: 10.1016/j.neuropharm.2013.08.035. Epub 2013 Sep 10. Review.

PMID:
24035919
3.

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.

Beevers JE, Caffrey TM, Wade-Martins R.

Biochem Soc Trans. 2013 Dec;41(6):1503-8. doi: 10.1042/BST20130194. Review.

PMID:
24256244
4.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
5.

α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Covy JP, Giasson BI.

Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14. Review.

6.

Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Le Grand JN, Gonzalez-Cano L, Pavlou MA, Schwamborn JC.

Cell Mol Life Sci. 2015 Feb;72(4):773-97. doi: 10.1007/s00018-014-1774-1. Epub 2014 Nov 18. Review.

PMID:
25403878
7.

[Molecular basis of Parkinson's disease linked with mutations in the LRRK2 gene].

Pchelina SN, emel'ianov AK, Usenko TS.

Mol Biol (Mosk). 2014 Jan-Feb;48(1):3-14. Review. Russian.

8.

Synaptic dysfunction in Parkinson's disease.

Picconi B, Piccoli G, Calabresi P.

Adv Exp Med Biol. 2012;970:553-72. doi: 10.1007/978-3-7091-0932-8_24. Review.

PMID:
22351072
9.

Genetics of Parkinson's disease: a review of SNCA and LRRK2.

Konno T, Siuda J, Wszolek ZK.

Wiad Lek. 2016;69(3 Pt 1):328-32. Review.

PMID:
27486710
10.

LRRK2 pathobiology in Parkinson's disease.

Martin I, Kim JW, Dawson VL, Dawson TM.

J Neurochem. 2014 Dec;131(5):554-65. doi: 10.1111/jnc.12949. Epub 2014 Oct 10. Review.

11.

Cellular reprogramming: a new approach to modelling Parkinson's disease.

Hartfield EM, Fernandes HJ, Vowles J, Cowley SA, Wade-Martins R.

Biochem Soc Trans. 2012 Oct;40(5):1152-7. Review.

PMID:
22988881
12.

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.

Zuo L, Motherwell MS.

Gene. 2013 Dec 10;532(1):18-23. doi: 10.1016/j.gene.2013.07.085. Epub 2013 Aug 15. Review.

PMID:
23954870
13.

A BACwards glance at neurodegeneration: molecular insights into disease from LRRK2, SNCA and MAPT BAC-transgenic mice.

Johnson SJ, Wade-Martins R.

Biochem Soc Trans. 2011 Aug;39(4):862-7. doi: 10.1042/BST0390862. Review.

PMID:
21787314
14.

Understanding the molecular causes of Parkinson's disease.

Wood-Kaczmar A, Gandhi S, Wood NW.

Trends Mol Med. 2006 Nov;12(11):521-8. Epub 2006 Oct 5. Review.

PMID:
17027339
15.

Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Gandhi PN, Chen SG, Wilson-Delfosse AL.

J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949. Review.

16.

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease.

Cookson MR.

Nat Rev Neurosci. 2010 Dec;11(12):791-7. doi: 10.1038/nrn2935. Epub 2010 Nov 19. Review.

17.

Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.

Büeler H.

Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Review.

PMID:
19303005
18.

Parkinson's disease.

Thomas B, Beal MF.

Hum Mol Genet. 2007 Oct 15;16 Spec No. 2:R183-94. Review.

PMID:
17911161
19.

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease.

Kang JF, Tang BS, Guo JF.

Stem Cells Int. 2016;2016:4126214. doi: 10.1155/2016/4126214. Epub 2016 Jan 6. Review.

20.

Clinical genetics of Parkinson's disease and related disorders.

Wider C, Wszolek ZK.

Parkinsonism Relat Disord. 2007;13 Suppl 3:S229-32. doi: 10.1016/S1353-8020(08)70007-5. Review.

PMID:
18267241

Supplemental Content

Support Center